From Now to Next: Maryland's Next Decade in Life Sciences

BioBuzz

Insights to Impact is a highly curated, 9-part event series exclusively for biopharma industry leaders and professionals, hosted by BioBuzz

4 N Martin Luther King Jr Blvd

BioHealth Capital Region Insights to Impact Series

Join us for BioBuzz's new signature event series, Insights to Impact.

This highly curated, invite-only series for industry leaders and executives is focused on industry insights and the most important factors impacting your organization today.

Join us for BioBuzz's new signature event series, Insights to Impact.This highly curated, invite-only series for industry leaders and executives is focused on industry insights and the most important factors impacting your organization today. Join us as we deliver thoughtful programming and engaging discussions that provide real value and learning, and foster meaningful connections and actionable insights. <h3>🔬 Forward-Thinking, Future-Building | Maryland’s Path to 2035</h3>What will Maryland’s life sciences sector look like in 2035 - and who will lead it there?Join an exclusive gathering of senior executives, scientific visionaries, policy leaders, and innovation architects for a bold conversation about the future of life sciences in Maryland. Designed for decision-makers and forward-thinkers, this event offers an immersive, high-level look into the decade ahead.Together, we’ll explore the forces reshaping our industry and ask the questions that demand new thinking, new partnerships, and decisive action.

<h4>What we’ll explore:</h4>🏭 Biomanufacturing of the FutureHow can Maryland become the go-to destination for advanced biomanufacturing and commercialization? What infrastructure, policy, and talent shifts are needed to scale innovation from lab to market faster?🧠 AI, Digital Health &amp; Data DominanceWill AI revolutionize clinical trials and drug development—or introduce new ethical risks and silos? How do we integrate data across systems to drive precision medicine and population health?🌎 Global Leadership from a Local HubCan Maryland become a global life sciences powerhouse—or will we lose ground to faster-moving ecosystems? What bold bets must we make today to lead tomorrow?🔗 Converging Sectors, Blurring LinesWhere are the next billion-dollar breakthroughs coming from—biotech, medtech, healthtech, software, or somewhere in between? What’s the role of cross-sector collaboration in driving life sciences innovation?👥 Talent, Equity &amp; The Workforce of 2035How do we build and retain the next-generation workforce—from cell therapy technicians to computational biologists? Can we scale without sacrificing inclusion, access, and purpose?🤝 Public-Private Power PlaysWhat models of collaboration between government, academia, and industry will unlock exponential progress? Are we investing in the right incentives, partnerships, and platforms to future-proof Maryland? <h3>IMPORTANT INFORMATION</h3>This invite-only event is FREE for industry leaders and professionals, providing a unique opportunity to gain insights on important industry trends and connect with fellow life science professionals, entrepreneurs, and advocates in a peer-oriented setting. Vendor and service provider attendance is paid and restricted to ensure a high-value program.While we ask that you do not share the registration link publicly, we encourage you to share this with those in your network who are passionate about strengthening the BioHealth Capital Region’s biotech ecosystem and would benefit from attending.NOTE TO VENDORS + SERVICE PROVIDERSVendors that operate in the same category as any of our sponsors will be restricted from attendance unless pre-authorized by the associated sponsor. BioBuzz reserves the right to restrict registration and entry as we deem necessary. Refunds will be provided when tickets if/where necessary.

Tom is employed by Wexford Science + Technology as an Executive Vice President. In this role, he guides Wexford's implementation of its Knowledge Community strategy across their development stakeholders globally to position Wexford's research park developments as critical hubs in the regional innovation ecosystem. Tom is an engaging speaker who has recently delivered keynotes on creating innovation ecosystems and helping Universities, research institutions, cities, regions, and federal governments, leverage their research and technologies into knowledge-led economic development, at the Associated of University Research Parks, the Austin Chamber of Commerce, the Society for Research Administration, and the NATO Industry Summit. He has also appeared on CNBC, CBC, CNN, and CBS and his opinions have appeared in The Wall Street Journal, Business Week, Fortune, The Globe and Mail, and The New York Times, among others.Additionally, Tom serves as an innovation advisor to the Department of Foreign Affairs and International Trade – Canada; helping Canadian companies successfully expand their operations into the United States and assisting US companies in developing Canadian partnerships and markets. He also serves as an advisor to the North Atlantic Treaty Organization (NATO) on global innovation, and the Brookings Institution for Innovation District research and measurement. Previously, he served as Executive Vice President and Chief of Staff at Broadwing Inc., an NYSE-listed, telecommunications provider, providing executive leadership in the areas of corporate strategy, mergers and acquisitions, and innovation. Prior to that, he served as Special Assistant to United States Senator Richard G. Lugar (R-Ind.), providing advice on foreign policy issues. Tom also provided policy advise to the Reagan Administration and developed a research methodology that has become a standard at Congressional Quarterly magazine.

<a href="https://www.linkedin.com/in/matt-tremblay-ph-d-5671594a" title="https://www.linkedin.com/in/matt-tremblay-ph-d-5671594a" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Matt Tremblay, PhD</a>, is the Chief Executive Officer of <a href="https://blackbirdlab.org/" title="https://blackbirdlab.org/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Blackbird Laboratories</a>, a nonprofit technology development platform, and Managing Director of Blackbird BioVentures, an early stage biotech investment fund. Blackbird and Blackbird BioVentures aim to catalyze the creation of new medicines and enabling technologies in Baltimore.Prior to joining Blackbird, Tremblay was Chief Operating Officer of Scripps Research and its drug discovery division, Calibr. He earned his PhD in Chemistry at Columbia University. Following postdoctoral work in the laboratory of Peter Schultz, PhD, at Scripps Research, he led a group at the Genomics Institute of the Novartis Research Foundation until helping to launch and run Calibr for 10 years.

<a href="https://www.linkedin.com/in/murat-kalayoglu-614bb8/" title="https://www.linkedin.com/in/murat-kalayoglu-614bb8/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Murat Kalayoglu, MD, PhD</a> is Co-Founder of <a href="https://www.cartesiantherapeutics.com/" title="https://www.cartesiantherapeutics.com/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Cartesian Therapeutics</a> and served as the company's President and CEO prior to its merger with Selecta in November 2023.Prior to Cartesian, Dr. Kalayoglu was co-founder and CEO of Topokine, which he led from concept to late-stage clinical trials, followed by the successful sale to Allergen (NYSE: AGN). Dr. Kalayoglu was also a co-founder and COO of HealthHonors Corporation, which he led from concept to commercialization, followed by a successful sale to Healthways (NASDAQ:HWAY).Dr. Kalayoglu is a board-certified ophthalmologist who completed his residency and research Fellowship at Harvard, MD/PhD in immunology at the University of Wisconsin-Madison, and MBA from the MIT Sloan School of Management.

Dr. Eric Van Gieson has over 25 years of experience in developing medical technology in diagnostics and critical care with leadership roles in industry, academia, and government. At The Conafay Group, he uses his skills in building partnerships with the U.S. Government and industry to ensure a rapid transition of early-stage biotechnology platforms to end users.Dr. Van Gieson’s career in the federal government began in 2003 at the Johns Hopkins Applied Physics Laboratory (JHUAPL), where he served as Program Manager and Principal Professional Staff. After seven years at JHUAPL, he joined the Defense Threat Reduction Agency (DTRA) as a Senior Science and Technology Manager where he served as Chief of the Diagnostics, Disease Surveillance, and Threat Detection division.In 2014, Dr. Van Gieson became Director of Biosurveillance and Diagnostics at MRIGlobal and later joined the National Strategic Research Institute (NSRI) at the University of Nebraska as Chief Technology Officer. During his time at both institutions, Dr. Van Gieson worked together with private and interagency partners to develop a novel patient transport system, known as the Containerized BioContainment System (CBCS). This platform ultimately received an R&amp;D 100 Award, and multiple federal agencies have used it to transport patients from both the Ebola and COVID-19 outbreaks.After nearly two years at NSRI, Dr. Van Gieson served as a Program Manager at the Defense Advanced Research Projects Agency (DARPA). During his five years with the Agency, Dr. Van Gieson initiated programs to use host-based methods to mitigate the impacts of emerging diseases, as well as to optimize human performance. These programs enabled a new diagnostic paradigm that harnesses the epigenome with AI-based biological pathway analyses and led to new technologies that can both diagnose and prognose diseases, guide healthcare decisions, and enable the discovery of new medical therapies. Dr. Van Gieson’s DARPA work also created programs to prevent traumatic brain injury with molecular prophylaxes.Dr. Van Gieson worked to commercialize the technology emerging from his programs at DARPA. These commercialization efforts have led to &gt;$100M in commercial and private investment in DARPA technologies to ensure their transition to both commercial and public/military applications.Dr. Van Gieson received his Doctor of Philosophy degree in Biomedical Engineering and a Bachelor of Science degree in Chemical Engineering from the University of Virginia. He has publications on topics ranging from genomic analysis to unmanned systems autonomy and has served as the Chief Judge on the Nokia Sensing XChallenge and a Judge on the Qualcomm Tricorder XChallenge. In his free time, he enjoys spending time with his family, wrenching on old cars, wing foiling, mountain biking, and snowboarding.

<a href="https://www.linkedin.com/in/pel-ozel/" title="https://www.linkedin.com/in/pel-ozel/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Pelin Ozel</a> is the Hub Director for <a href="https://nucleate.org/locations/dc-baltimore/" title="https://nucleate.org/locations/dc-baltimore/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Nucleate DC/Baltimore</a> and a graduate student in the neuroscience department of Johns Hopkins School of Medicine.Prior to joining the <a href="https://sites.krieger.jhu.edu/knierim-lab/people/" title="https://sites.krieger.jhu.edu/knierim-lab/people/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Knierim lab</a>, she studied head direction cells during 3D navigational tasks in her honors thesis in the Taube lab. Now, she is using high-density silicon probes, Neuropixels, to investigate representational plasticity of place fields in the hippocampus. Broadly, she is interested in how non-spatial stimuli (such as rewards and visual information) can be integrated into the cognitive map model. Recent awards: F31 Ruth L. Kirschstein Predoctoral Individual National Research Service Awardee, OIST Computational Neuroscience Course (OCNC) Attendee, JHSOM GSA Travel Grant Awardee

<h3>4MLK</h3>4MLK, the newest addition to the University of Maryland BioPark, is an 8-story, 250,000 square foot multi-tenant lab and office building developed by Wexford Science &amp; Technology. Beyond its cutting-edge facilities, 4MLK offers accessible innovation and collaboration spaces, flexible lab spaces designed for start-ups and scaling companies at Connect Labs by Wexford, along with dynamic programming designed to drive economic development and foster engagement of the innovation community and surrounding neighborhoods. Serving as a center of gravity and congregation destination for the regional innovation ecosystem, it creates opportunities for connection, creativity, and inclusion.Learn more at <a href="https://www.4mlk.com/" title="https://www.4mlk.com/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">4mlk.com</a>.

<h3>ASCEND-ABL</h3>We are thrilled to have Ascend Advanced Therapies (Ascend) and Advanced BioScience Laboratories (ABL) as a Series Sponsor and our exclusive CDMO partner for all nine (9) of our Insights to Impact events this year.Ascend-ABL is a gene-to-GMP CDMO specializing in high-quality, cost-effective advanced therapy development and manufacturing. We are dedicated to advancing therapeutics, vaccines, and other biological products through effective partnership with our clients to patients in need.With ABL’s 60+ years of experience working on a diverse range of infectious diseases with organizations including industry, government, and academic entities plus Ascend’s 30+ years of AAV innovation expertise, Ascend-ABL provides robust capabilities for the development and production of multimodal virus-based oncolytic therapies, cell &amp; gene therapies, viral vaccines and immunotherapies from the bench to commercialization.Ascend-ABL has facilities in Rockville, MD, Alachua, FL, and Munich, Germany. Learn more about your long-time, BioHealth Capital Region neighbor, ABL at <a href="https://ablinc.com/" title="https://ablinc.com/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">abclinc.com</a> and be sure to FOLLOW them on <a href="https://www.linkedin.com/company/abl-inc/posts/?feedView=all" title="https://www.linkedin.com/company/abl-inc/posts/?feedView=all" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">LinkedIn</a>. Learn more about Ascend at <a href="http://www.ascend-adv.com/" title="http://www.ascend-adv.com/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">ascend-adv.com</a> and be sure to also FOLLOW them on <a href="https://www.linkedin.com/company/ascend-advanced-therapies/" title="https://www.linkedin.com/company/ascend-advanced-therapies/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">LinkedIn</a>.

<h3>CRB</h3>We are thrilled to have CRB Group as a Series Sponsor and the exclusive Design/Build partner for all nine (9) of our Insights to Impact events this year.CRB is a leading provider of sustainable engineering, architecture, construction and consulting solutions to the global life sciences and food and beverage industries.Learn more at <a href="https://www.globenewswire.com/Tracker?data=Th9lqXt_l7CPepdLwYy3EweBhLUE5W7LblkuOwG4uiEHMUCxp_LlqOMEC_rsR6DMYCbQtlxJgqpDGTWPu_KsnA==" title="https://www.globenewswire.com/Tracker?data=Th9lqXt_l7CPepdLwYy3EweBhLUE5W7LblkuOwG4uiEHMUCxp_LlqOMEC_rsR6DMYCbQtlxJgqpDGTWPu_KsnA==" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">crbgroup.com</a> and be sure to FOLLOW them on <a href="https://www.globenewswire.com/Tracker?data=PCdogvlGdSHhYf6C4bB0B367xh0nSbGkl0zzubpRlOt1xfiyvGwXfhWRKZBDhvJd7iL0BUvj_7zZI25jPtBuk8b5AEpzrTeFqozBxRBX3cA=" title="https://www.globenewswire.com/Tracker?data=PCdogvlGdSHhYf6C4bB0B367xh0nSbGkl0zzubpRlOt1xfiyvGwXfhWRKZBDhvJd7iL0BUvj_7zZI25jPtBuk8b5AEpzrTeFqozBxRBX3cA=" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">LinkedIn</a>. <h3>FULTON BANK</h3>We are thrilled to have Fulton Bank as a Series Sponsor and the exclusive Banking partner for all nine (9) of our Insights to Impact events this year.Fulton Bank supports your growth from concept to market. Life sciences and technology sectors are rapidly evolving and their Life Sciences &amp; Technology Group is transforming the way they support your unique needs.From vaccines to medical devices and from cyber to ag tech, Fulton's expertise enables you to focus on making a difference, not on day-to-day finances. Whatever stage you’re in—startup, early growth, or established company—our dedicated team offers products, services, and resources designed to help you succeed.Learn more at <a href="https://www.fultonbank.com/Commercial/Spotlight-On-Industries/Life-Sciences-and-Technology" title="https://www.fultonbank.com/Commercial/Spotlight-On-Industries/Life-Sciences-and-Technology" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">fultonbank.com</a> and be sure to FOLLOW them on <a href="https://www.linkedin.com/company/fulton-bank/posts/?feedView=all" title="https://www.linkedin.com/company/fulton-bank/posts/?feedView=all" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">LinkedIn</a>.

<h3>HEFFRON</h3>We are thrilled to have Heffron as a Series Sponsor and the exclusive Construction partner for all nine (9) of our Insights to Impact events this year.At Heffron, relationships are the backbone of our business. We build hospitals and biotech labs to save lives and discover new breakthrough cures. We were founded on a bedrock of dedication, hard work, and family. For more than a century, we have been serving our clients with excellence in mechanical and energy services in the DC metropolitan region. Learn more at <a href="https://www.heffroncompany.com/" title="https://www.heffroncompany.com/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">heffroncompany.com</a> and be sure to FOLLOW them on <a href="https://www.globenewswire.com/Tracker?data=PCdogvlGdSHhYf6C4bB0B367xh0nSbGkl0zzubpRlOt1xfiyvGwXfhWRKZBDhvJd7iL0BUvj_7zZI25jPtBuk8b5AEpzrTeFqozBxRBX3cA=" title="https://www.globenewswire.com/Tracker?data=PCdogvlGdSHhYf6C4bB0B367xh0nSbGkl0zzubpRlOt1xfiyvGwXfhWRKZBDhvJd7iL0BUvj_7zZI25jPtBuk8b5AEpzrTeFqozBxRBX3cA=" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">LinkedIn</a>. <h3>HENRY JACKSON FOUNDATION</h3>We are thrilled to have The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) as a Series Sponsor for all nine (9) of our Insights to Impact events this year.HJF is a 501(c)(3) nonprofit organization dedicated to advancing military medicine. We serve military, medical, academic and government clients by administering, managing and supporting preeminent scientific programs that benefit members of the armed forces and civilians alike.Since its founding in 1983, HJF has served as a vital link between the military medical community and its federal and private partners. HJF's support and administrative capabilities allow military medical researchers and clinicians to maintain their scientific focus and accomplish their research goals.Learn more at <a href="https://www.hjf.org/" title="https://www.hjf.org/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">hjf.org</a> and be sure to FOLLOW them on <a href="https://www.linkedin.com/company/hjf/" title="https://www.linkedin.com/company/hjf/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">LinkedIn</a>.

<h3>IBT BioServices</h3>We are thrilled to have IBT BioServices as a Floating Sponsor for this event.IBT BioServices is a full service CRO for all pre-clinical testing needs for infectious disease product development! Our team has extensive experience in antibacterial and antiviral testing, vaccine research, immunology, and reagent and assay development. IBT boasts 15+ highly relevant and validated small animal models for infections up to BSL-2 in-house and BSL-3 &amp; BSL-4 models through partners. With a strong client-oriented approach, IBT also specializes in animal model optimization and new model development to address needs of modern therapeutics. IBT has been a pioneer in emerging infectious disease research at the forefront of global public health initiatives since 2005.Learn more at <a href="https://www.ibtbioservices.com" title="https://www.ibtbioservices.com" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">ibtbioservices.com</a> and be sure to FOLLOW them on <a href="https://www.linkedin.com/company/ibt-bioservices-llc" title="https://www.linkedin.com/company/ibt-bioservices-llc" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">LinkedIn</a>. <h3>INFOPATHWAYS</h3>We are thrilled to have InfoPathways as a Series Sponsor and the exclusive Information Technology partner for all nine (9) of our Insights to Impact events this year.InfoPathways is not just an IT firm; we are your trusted partner in navigating the intricate landscape of the life sciences industry. We offer comprehensive solutions that encompass IT support, cybersecurity, data management, technology planning, and beyond.Learn more at <a href="https://infopathways.com/" title="https://infopathways.com/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">infopathways.com</a> and be sure to FOLLOW them on <a href="https://www.linkedin.com/company/infopathways/posts/?feedView=all" title="https://www.linkedin.com/company/infopathways/posts/?feedView=all" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">LinkedIn</a>. <h3>PROJECT FARMA</h3>We are thrilled to have Project Farma as a Series Sponsor for all nine (9) of our Insights to Impact events this year.Project Farma is a patient-focused global leader in advancing technical operations from ideation through commercialization with a proven track record of planning, building, and maintaining manufacturing facilities, capital expansions, and technical operations for complex biologics and novel modalities. Project Farma has executed 100+ facility builds, retrofits and expansions, managed 400+ large scale capital projects, industrialized 10+ commercial cell, gene, and novel therapies, and managed $6B+ in technical operations capital investments.Partnering with leading pharmaceutical companies, advanced therapy organizations, universities, hospitals, and government agencies, our team of experts drives innovation in technical operations and manufacturing to support advancement of groundbreaking therapies for patients in need.Learn more at <a href="https://www.projectfarma.com/" title="https://www.projectfarma.com/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">projectfarma.com</a> and be sure to FOLLOW them on <a href="https://www.linkedin.com/company/projectfarma/posts/?feedView=all" title="https://www.linkedin.com/company/projectfarma/posts/?feedView=all" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">LinkedIn</a>.

<h3>QIAGEN</h3>We are thrilled to have QIAGEN as a Series Sponsor and the exclusive Tools partner for all nine (9) of our Insights to Impact events this year.QIAGEN offers Sample to Insight solutions, products and services that enable customers worldwide to advance science, improve patient outcomes and gain valuable insights from biological samples.Learn more at <a href="https://www.qiagen.com/us" title="https://www.qiagen.com/us" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">qiagen.com</a> and be sure to FOLLOW them on <a href="https://www.linkedin.com/company/qiagen/posts/?feedView=all" title="https://www.linkedin.com/company/qiagen/posts/?feedView=all" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">LinkedIn</a>.

<h3>TEDCO</h3>We are thrilled to have the Maryland Technology Development Corporation (TEDCO) as a Series Sponsor all nine (9) of our Insights to Impact events this year.TEDCO enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland.Learn more at <a href="https://www.tedcomd.com/" title="https://www.tedcomd.com/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">tedcomd.com</a> and be sure to FOLLOW them on <a href="https://www.linkedin.com/company/maryland-technology-development-corporation-tedco-/" title="https://www.linkedin.com/company/maryland-technology-development-corporation-tedco-/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">LinkedIn</a>.

<h3>WEXFORD SCIENCE &amp; TECHNOLOGY</h3>We are thrilled to have Wexford Science &amp; Technology as a Floating Sponsor for this event.Wexford Science &amp; Technology, LLC, is a real estate company exclusively focused on partnering with universities, academic medical centers, and research institutions to develop vibrant, mixed-use, amenity-rich Knowledge Communities that are built on a foundation of research, discovery, innovation, entrepreneurial activity, corporate engagement, and community inclusion. These Knowledge Communities create visible outcomes in the form of substantial economic growth, new and diverse jobs, and community transformation.Learn more at <a href="https://wexfordscitech.com/" title="https://wexfordscitech.com/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">wexfordscitech.com</a>. <h3>WORKFORCE GENETICS</h3>We are thrilled to have Workforce Genetics (WGx) as a Series Sponsor and the exclusive Talent partner for all nine (9) of our Insights to Impact events this year.WGx is a premier recruiting firm dedicated to the life sciences and healthcare sectors. With a focus on building transformative talent solutions for companies of all sizes, the firm offers comprehensive recruitment solutions, including retained and executive search, contingent search, and outsourced talent acquisition.Learn more at <a href="https://workforcegenetics.com/" title="https://workforcegenetics.com/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">workforcegenetics.com</a> and be sure to FOLLOW them on <a href="https://www.linkedin.com/company/workforce-genetics/?viewAsMember=true" title="https://www.linkedin.com/company/workforce-genetics/?viewAsMember=true" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">LinkedIn</a>.

<h3>FUNKTIONAL BREWING COMPANY</h3>We are thrilled to have Funktional Brewing Company as our exclusive Craft Beer 2.0 partner.Designed and brewed by scientists in Frederick, MD, Funktional Brewing Company thinks you should get more out of your beer. They brew craft beer with functional ingredients that promote health, wellness, active lifestyle, and longevity. Their natural and organic adaptogenic and nootropic ingredients have been thoughtfully crafted into their beers balanced for flavor and 'funktion.'Learn more at <a href="https://funktional.beer/https://funktional.beer/" title="https://funktional.beer/https://funktional.beer/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">funktional.beer</a> and be sure to FOLLOW them on <a href="https://www.linkedin.com/company/funktional-brewing-company/" title="https://www.linkedin.com/company/funktional-brewing-company/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">LinkedIn</a>.

<h3>WILD BAY</h3>We are thrilled to have Wild Bay as our exclusive Non-Alcoholic Beverage partner.Based in Baltimore, MD, Wild Bay is an organic beverage manufacturer and distributor.Learn more at <a href="https://wildbaykombucha.com/" title="https://wildbaykombucha.com/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">wildbaykombucha.com</a> and be sure to FOLLOW them on <a href="https://www.linkedin.com/company/wildbay/posts/?feedView=all" title="https://www.linkedin.com/company/wildbay/posts/?feedView=all" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">LinkedIn</a>.

<h3>DONATIONS</h3>All ticket sale donations will support the BioBuzz Student Ambassador Workforce Development Program that BioBuzz is launching this Fall.The Program is built on a community-driven model that empowers students, engages employers, and fosters meaningful connections across campuses, the region, and the industry.

Agenda

Check-In + Networking

Welcome

Panel: Maryland's Next Decade in Life Sciences

Networking

Our {communityGuidelinesLink} describe the sort of content we prohibit on Eventbrite. If you suspect an event may be in violation, you can report it to us so we can investigate.

To report other categories of prohibited or illegal content, submit {link}

From Now to Next: Maryland's Next Decade in Life Sciences

More events from BioBuzz

Discover more events from BioBuzz, from Science & Tech to other experiences you might love.

From Now to Next: Maryland's Next Decade in Life Sciences

More events from BioBuzz

Discover more events from BioBuzz, from Science & Tech to other experiences you might love.

You might also like...

Browse more events with different dates, prices, and formats to find your next great experience.